ANGELA WEBB: Open Payments
NPI 1639553704 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 15 payments from 9 companies in 2025. Trend: 2023 $235 · 2024 $196 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: INGREZZA, Auvelity, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, CAPLYTA, Wegovy, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
